Solid Dosage
GEA offers a complete range of technologies for the high-volume production of solid OTC Painkillers, Analgesics and Fever Relief products
The fast and reliable release of active ingredients is becoming increasingly important, particularly for analgesic drugs. Customer expectations of over-the-counter (OTC) painkillers are “fast and effective” results for immediate relief. At the same time, these dosage forms need to be easy to take and relatively inexpensive.
Beyond rapid action, for example, the benefits of effervescent tablets include an opportunity for formulators to improve the taste of their oral dosage form, a less aggressive delivery method and the consumer appeal associated with taking a fizzy tablet.
Plus, with various market players now developing combination (bilayer) drugs, the need for commercial-scale double-sided rotary tablet presses has never been greater. Designed for the reliable and cost-effective large-scale production of oral solid dosage forms, GEA’s portfolio includes models that combine the benefits of flexibility and robust performance for a wide range of formulations.
Experts in every aspect of high-volume batch processing, GEA offers a complete range of technologies for the production of solid dosage forms: from powder handling to granulating, drying, tablet compression and coating. And, from R&D through scale-up to commercial production, we can identify the most appropriate solution for your specific application and meet your technical requirements.
GEA’s entire range of process equipment is designed with system integration in mind. A modular approach allows customers to select standard process modules to suit their needs. Furthermore, our rotary tablet presses provide a number of options for the high-volume production of large tablets, including continuous manufacturing in low humidity environments.
Affichage de 4 sur 26

Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.

The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.

At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.

Le nouveau Centre d’application et de technologie (ATC) GEA de Sarstedt, au sud de Hanovre, n’est ni un showroom ni un ersatz de laboratoire. C’est un lieu conçu pour les essais, la collecte de données et les décisions précoces. Un endroit où l’on détermine si un concept biologique peut devenir un procédé industriel robuste. Cette étape est plus importante qu’il n’y paraît.

Si le thermoformage joue depuis longtemps un rôle central dans le domaine de l'emballage alimentaire, il doit aujourd'hui affronter un tournant majeur. À une époque comme la nôtre où les réglementations se durcissent, où les matériaux évoluent et où les coûts augmentent, il ne suffit plus que les lignes de conditionnement FFS ou <i>Form-Fill-Seal</i> (Former-Remplir-Sceller) fonctionnent de manière fiable : elles sont désormais déterminantes pour garantir la fraîcheur des denrées, un prix accessible et la recyclabilité. Examinez de plus près les grandes tendances qui dans le domaine du thermoformage façonnent le secteur de l'emballage et de la distribution alimentaires.